IIIbinabo Ibiebele

Ibinabo Ibiebele

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ibinabo Ibiebele has a total of 202 co-authors. Here are the top co-authors by number of shared publications:

  • Tanya A. Nippita

    Sydney Medical School The University of Sydney Sydney Australia

    13 shared publications
  • Siranda Torvaldsen

    Clinical and Population Perinatal Health Research, Kolling Institute, Northern Sydney Local Health District, St Leonards, NSW, Australia

    10 shared publications
  • Siranda Torvaldsen

    Kolling Institute, Northern Sydney Local Health Sydney New South Wales Australia

    8 shared publications
  • Jane B. Ford

    Women and Babies Research The University of Sydney Northern Clinical School St Leonards NSW Australia

    7 shared publications
  • Deborah Randall

    Reproduction and Perinatal Centre – Northern Precinct, Faculty of Medicine and Health, the University of Sydney Sydney New South Wales Australia

    6 shared publications
  • Tanya Nippita

    Reproduction and Perinatal Centre – Northern Precinct, Faculty of Medicine and Health, the University of Sydney Sydney New South Wales Australia

    6 shared publications

Latest Publications

  • Open Access

    Hand Hygiene Compliance and Postpartum Infections

    by Catherine Louise Crouch, Ibinabo Ibiebele, Biny Mathews, Tanya A. Nippita

  • Open Access

    Outcomes for Women With Diabetes at Late Preterm Gestation Who Received Antenatal Corticosteroids: A Population‐Based Cohort Study

    by Ibinabo Ibiebele, Kata Kraljevic, Sarah Glastras, Tessa Weir, Deborah Randall, Tanya Nippita

    Background: The use of antenatal corticosteroids appears to be increasing despite limited and conflicting evidence about its efficacy among women with diabetes in pregnancy. Aim: To separately assess the effects of maternal diabetes and the effects of antenatal corticosteroid administration prior to late preterm birth on adverse maternal and neonatal outcomes. Materials and Methods: Cohort study of women who gave birth ≥ 35 weeks gestation between September 2016 and March 2021 in two local health districts in New South Wales, Australia. Women were grouped into one of the following: (1) diabetes and received corticosteroids, (2) diabetes and no corticosteroids, (3) no diabetes and received corticosteroids. Modified Poisson regression was used to estimate adjusted relative risks (aRR). Results: A total of 5 067 women were included (Group 1 = 205, Group 2 = 4 028, Group 3 = 834). Women who received corticosteroids were characterised by higher proportions of hypertension, hospital‐based medical antenatal care, multiple births and caesarean section. There were no differences in maternal and neonatal outcomes for women who had diabetes and received corticosteroids compared to those who had diabetes and did not receive corticosteroids. Women with diabetes who received corticosteroids had a higher risk of infants with neonatal hypoglycaemia (aRR 1.61, 95% CI 1.28–2.02) and admission to nursery or intensive care unit (aRR 1.18, 95% CI 1.02–1.38), compared to women without diabetes who received corticosteroids. Conclusions: There is limited evidence of benefit for the use of antenatal corticosteroids in late preterm gestations, regardless of diabetes status. Further studies are required to identify potential longer‐term benefits or harms.

  • Postpartum haemorrhage following second birth in women with caesarean first birth: a population-based study

    by Grace Iona Jessie Pickering, Ibinabo Ibiebele, Kassam Mahomed

  • Open Access

    Neonatal Outcomes Following Preterm Birth Between 28 and 36 Weeks’ Gestation in Vietnam: A Cohort Study

    by Quynh T. T. Tran, Sean K. Seeho, Tanya A. Nippita, Jonathan M. Morris, Thanh Q. Le, Hai N. Tran, Hai T. Pham, Ibinabo Ibiebele

    Background: Preterm birth leads to adverse neonatal outcomes. Data on neonatal outcomes in middle‐income settings like Vietnam are lacking. Aims: Describe preterm neonatal outcomes in Vietnam. Materials and Methods: Retrospective cohort study including all live singleton births at 28–36 weeks’ gestation in Vietnam from June 2019 to June 2020. Outcomes included neonatal morbidity and mortality and were examined by labour onset and gestational age groups. Logistic regression was used to estimate the odds of neonatal morbidity and mortality following planned birth (labour induction and prelabour caesarean) relative to spontaneous birth. Results: Among 5374 live singleton preterm births, 663 (12.4%) occurred between 28 and 31 weeks, 824 (15.3%) between 32 and 33 weeks and 3887 (72.3%) between 34 and 36 weeks; 2765 (51.5%) births followed spontaneous labour and 2616 (48.5%) were planned births. Mortality rates decreased with increasing gestational age. More than 90% of neonates born at 28–33 weeks had morbidity, with the rate of morbidity decreasing from 34 weeks. The odds of mortality were no different following labour induction (aOR 1.22, 95% CI, 0.72–2.09) or prelabour caesarean (aOR 1.04, 95% CI, 0.63–1.73) compared with spontaneous labour. The odds of morbidity were higher among pregnancies following labour induction (aOR 1.53, 95% CI, 1.31–1.80) and prelabour caesarean section (aOR 2.14, 95% CI, 1.84–2.50) than spontaneous labour. Among planned preterm births < 35 weeks, antenatal corticosteroids were associated with higher morbidity (90.7% vs. 74.3%, p < 0.001) and lower mortality rates (2.5% vs. 5.1%, p = 0.022). Conclusions: Preterm neonates born before 34 weeks are at particularly high likelihood of morbidity and mortality, with planned preterm birth associated with a higher rate of morbidity.

  • Open Access

    Bariatric Surgery, Gestational Diabetes and Perinatal Outcomes: A Population‐Based Study

    by Tessa Weir, Ibinabo Ibiebele, Deborah Randall, Tanya Nippita, Siranda Torvaldsen, Felicity Gallimore, Jonathan Morris, Sarah Glastras

    Objective: To examine the independent and combined associations of metabolic and bariatric surgery (MBS) and gestational diabetes mellitus (GDM) with adverse maternal and neonatal outcomes. Design: Population‐based retrospective cohort study. Setting: New South Wales (NSW), Australia. Population: Four hundred twenty‐nine thousand five hundred seventy‐six singleton births from 2016 to 2020 in NSW, including 3001 women with a history of MBS. Methods: Linked perinatal and hospital data were used to classify women into four groups: no MBS/no GDM, MBS/no GDM, GDM/no MBS, and GDM/MBS. Multivariable logistic regression was used to examine associations with adverse outcomes, adjusting for maternal age, BMI, parity, smoking, country of birth, and gestational age. Main Outcome Measures: Neonatal and maternal outcomes including preterm birth, (large‐for‐gestational‐age) LGA, small‐for‐gestational‐age (SGA), neonatal hypoglycaemia, preeclampsia and postpartum haemorrhage. Results: Women with both GDM and prior MBS had the highest odds of adverse outcomes. Compared to women without GDM or surgery, this group had increased odds of LGA (aOR 1.42, 95% CI 1.22–1.65), preterm birth (aOR 1.93, 95% CI 1.52–2.42), and neonatal hypoglycaemia (aOR 4.98, 95% CI 4.22–5.84). Preeclampsia risk was modestly increased across all groups but attenuated after BMI adjustment. Postpartum haemorrhage was reduced in women with prior surgery (aOR 0.81, 95% CI 0.72–0.92), while induction of labour was more likely in all exposure groups. Conclusions: gestational diabetes mellitus (GDM) and prior MBS confer independent and combined risks for adverse perinatal outcomes. These findings support the need for personalised antenatal care strategies in this high‐risk population.


  • Open Access

    StUdy of Gestational diabetes And Risk using Electronic Data (SUGARED): a population-based cohort study—study protocol

    by Deborah Randall, Ibinabo Ibiebele, Tanya Nippita, Siranda Torvaldsen, Jonathan M Morris, Felicity Gallimore, Tessa L Weir, Sarah Glastras

    Introduction The incidence of gestational diabetes mellitus (GDM) in Australia has tripled in the last 20 years. Consequently, over 40 000 pregnancies are now diagnosed as ‘higher risk’ each year. This has increased antenatal surveillance and obstetric intervention, often in the form of delivery earlier than 39 weeks gestation. The StUdy of Gestational diabetes And Risk using Electronic Data (SUGARED) project aims to use large population-based and routinely collected linked health data to (1) personalise risk prediction of adverse pregnancy outcomes for women undergoing glucose tolerance testing, (2) guide optimal birth timing for women with diet-controlled GDM and (3) examine variation in GDM management and pregnancy outcomes in New South Wales (NSW), Australia. Methods and analysis This retrospective cohort study using linked, routinely collected health data includes all women who gave birth from January 2016 to December 2020 in NSW. The cohort will include approximately 475 000 pregnancies, with >70 000 diagnosed with GDM. The study will link birth data to hospital data and birth/death registry data. In addition, clinical pathology results and detailed clinical information from a subset of public hospital pregnancies in 13 of 15 area health services will be linked. To address the three main aims, we will use statistical methods including logistic regression and K-fold cross-validation for risk prediction, a propensity-score matching ‘target trial’ method to examine birth timing, and multilevel modelling to examine hospital variation. Ethics and dissemination Ethics approval for the study has been granted by the NSW Population and Health Services Research Ethics Committee. We will communicate evidence generated from SUGARED to the local health districts and their clinicians, as well as potentially optimising dissemination using existing digital infrastructure.


  • Gender representation in obstetrics and gynaecology leadership

    by Belinda Holmes, Ibinabo Ibiebele, Tanya A.C. Nippita

    Background: Women in leadership in obstetrics and gynaecology in Australia and Aotearoa New Zealand have historically been underrepresented, despite forming a significant portion of the workforce. This study extends prior research from 2017, examining shifts in gender representation, attitudes, and perceived leadership barriers within the specialty.Aims: The study aims to evaluate changes in gender diversity among leadership positions in the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) and accredited training hospitals since 2017. Additionally, it seeks to understand current attitudes toward leadership and identify perceived barriers among RANZCOG consultants and trainees.Materials and Methods: A cross‐sectional approach was employed, utilising publicly available information, a survey distributed to RANZCOG members, and data from accredited training hospitals. Gender representation in leadership positions was analysed, and survey responses were collected from consultants and trainees to evaluate attitudes and perceived barriers.Results: The study reveals an increase in women's representation in RANZCOG leadership, particularly on the council and in clinical leadership positions. While the proportion of women trainees remained stable, there was a noteworthy increase in women specialists. Survey responses revealed shared perceptions on leadership qualities but diverged on barriers, with more women expressing concerns about skillsets, caring responsibilities, and mentorship support.Conclusions: The findings underscore substantial progress in achieving gender equity in obstetrics and gynaecology leadership roles, attributed to RANZCOG initiatives, societal changes, and improved policies. Ongoing efforts, including structured mentorship and flexible arrangements, are recommended to sustain and further enhance gender representation and address specific barriers identified by women in the specialty.


  • Open Access

    Asymptomatic bacteriuria in pregnancy

    by Madeleine Sheppard, Ibinabo Ibiebele, Tanya Nippita, Jonathan Morris

    Background: Asymptomatic bacteriuria (ASB) is associated with adverse maternal and neonatal outcomes and is routinely screened for and treated in the first trimester. Prevalence of ASB in the second and third trimesters of pregnancy is unknown.Aims: The aim is to determine the prevalence of ASB in the second and third trimesters of pregnancy.Methods: Prospective cohort study of 150 pregnant women. Mid‐stream urine samples were tested for ASB in the second (24–28+6) and third (32–36+6) trimesters. Women were assigned to one of two groups: (i) ASB in any trimester of pregnancy and (ii) no evidence of ASB in pregnancy. Maternal and neonatal outcomes were compared between groups.Results: Among 143 women included in the study, the rate of ASB was 4.9% (2.1, 2.1 and 3.2% in the first, second and third trimesters, respectively). Of those with ASB, 14% had it in every trimester, whereas 43% had it on two or more samples. Of those with ASB in pregnancy, 43% were detected for the first time in the third trimester. Rates of maternal and neonatal outcomes were not statistically significantly different between the two groups. No women with ASB were induced for chorioamnionitis or growth restriction.Conclusion: The rate of ASB was highest in the third trimester of pregnancy, with rates of 2.1, 2.1 and 3.2% in the first, second and third trimesters, respectively. This study was underpowered to assess maternal and fetal outcomes. Although numbers were small, the absence of ASB in the first trimester was a poor predictor of ASB in the third trimester.


  • Open Access

    Trends in early gestation stillbirths and neonatal deaths in New South Wales, Australia 2002–2019

    by Marissa Parry, Siranda Torvaldsen, Tanya A. Nippita, Jennifer Bowen, Jonathan M. Morris, Ibinabo Ibiebele

    BackgroundLittle research has focused on understanding trends in early gestation (20-27 weeks) stillbirths and neonatal deaths.AimsTo examine trends in early gestation stillbirths and neonatal deaths in New South Wales (NSW), Australia.Materials and MethodsPopulation-based cohort study of all births >= 20 weeks gestation among female NSW residents during 2002 to 2019, induced pregnancy terminations excluded. Stillbirth rates by gestational age and birth year were calculated per 1000 fetuses-at-risk (FAR). Neonatal death rates by gestational age and birth year were calculated per 1000 live births. Linear regression was used to examine trends in stillbirth and neonatal death rates among all, singleton and twin births.ResultsDeclining trends in early gestation stillbirth and neonatal death rates were found. Stillbirth rates decreased from 1.9 and 0.9/1000 FAR in 2002 to 1.6 and 0.7 in 2019 for 20-23 and 24-27 week groups, respectively. Neonatal rates decreased from 940 and 315/1000 live births in 2002 to 925 and 189 in 2019 for the 20-23 and 24-27 week groups, respectively. Among singleton births, declining trends in stillbirth and neonatal death rates across all age groups were observed, except for 37-38 week stillbirths. No trends in twin stillbirth rates were found across gestational age groups, although a decreasing trend was observed for 20-23 week twin neonatal deaths.ConclusionsTrends in early gestation stillbirth and neonatal deaths have declined in recent decades in NSW but further efforts are needed to reduce both early and late gestation stillbirth rates among twin births.

  • Open Access

    Pregnancy outcomes in women with endometriosis and/or ART use: a population-based cohort study

    by Ibinabo Ibiebele, Tanya Nippita, Rodney Baber, Siranda Torvaldsen

    STUDY QUESTION: What is the association between endometriosis and adverse pregnancy outcomes with ART use and non-use? SUMMARY ANSWER: Endometriosis and ART use are both associated with increased risk of preterm birth, antepartum haemorrhage, placenta praevia and planned birth (caesarean delivery or induction of labour). WHAT IS KNOWN ALREADY: There are contradictory findings on the association between endometriosis and adverse pregnancy outcomes, and many large studies have not considered the effect of ART use. STUDY DESIGN, SIZE, DURATION: Population-based cohort study of 578 221 eligible pregnancies during 2006–2015, comparing pregnancy outcomes across four groups (No endo/no ART, No endo/ART, Endo/no ART and Endo/ART). PARTICIPANTS/MATERIALS, SETTING, METHODS: All female residents of New South Wales, Australia aged 15–45 years and their index singleton pregnancy of at least 20 weeks gestation or 400 g birthweight. Linked hospital, pregnancy/birth and mortality data were used. Modified Poisson regression with robust error variances was used to estimate adjusted risk ratios (aRRs) and 99% CIs, adjusting for sociodemographic and pregnancy factors. MAIN RESULTS AND THE ROLE OF CHANCE: Compared to women without endometriosis who had pregnancies without ART use, there was increased risk of preterm birth (<37 weeks) in all groups [No endo/ART (aRR 1.85, 99% CI 1.46–2.34), Endo/no ART (aRR 1.24, 99% CI 1.06–1.44), Endo/ART (aRR 1.93, 99% CI 1.11–3.35)] and antepartum haemorrhage [No endo/ART (aRR 1.99, 99% CI 1.39–2.85), Endo/no ART (aRR 1.31, 99% CI 1.03–1.67), Endo/ART (aRR 2.69, 99% CI 1.30–5.56)] among pregnancies affected by endometriosis or ART use, separately and together. There was increased risk of placenta praevia [No endo/ART (aRR 2.26, 99% CI 1.42–3.60), Endo/no ART (aRR 1.66, 99% CI 1.18–2.33)] and planned birth [No endo/ART (aRR 1.08, 99% CI 1.03–1.14), Endo/no ART (aRR 1.11, 99% CI 1.07–1.14)] among pregnancies with endometriosis or ART use, separately. There was increased risk of placental abruption [No endo/ART (aRR 2.36, 99% CI 1.12–4.98)], maternal morbidity [No endo/ART (aRR 1.67, 99% CI 1.07–2.62)] and low birthweight (<2500 g) [No endo/ART (aRR 1.45, 99% CI 1.09–1.93)] among pregnancies with ART use without endometriosis. There was decreased risk of having a large-for-gestational age infant [Endo/no ART (aRR 0.83, 99% CI 0.73–0.94)] among pregnancies with endometriosis without ART use. LIMITATIONS, REASONS FOR CAUTION: Endometriosis is often under-diagnosed and women with a history of hospital diagnosis of endometriosis may represent those with more symptomatic or severe disease. If the effects of endometriosis on pregnancy are greater for those with more severe disease, our results may over-estimate the effect of endometriosis on adverse pregnancy outcomes at a population level. We were unable to assess the effect of endometriosis stage or typology on the study outcomes. WIDER IMPLICATIONS OF THE FINDINGS: These results suggest that women with endometriosis including those who used ART to achieve pregnancy are a higher-risk obstetric group requiring appropriate surveillance and management during their pregnancy. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the Prevention Research Support Program, funded by the New South Wales Ministry of Health. The funder had no role in the design, data collection and analysis, interpretation of results, manuscript preparation or the decision to submit the manuscript for publication. The authors have no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.